SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000903423-16-001320
Filing Date
2016-10-26
Accepted
2016-10-26 17:49:47
Documents
1
Period of Report
2016-10-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT glaxo-crispr.html 4  
1 OWNERSHIP DOCUMENT glaxo-crispr.xml 4 12088
  Complete submission text file 0000903423-16-001320.txt   13626
Mailing Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS
Business Address 980 GREAT WEST ROAD BRENTFORD MIDDLESEX X0 TW8 9GS 011442080475000
GLAXOSMITHKLINE PLC (Reporting) CIK: 0001131399 (see all company filings)

State of Incorp.: X0
Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 161953469
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478
SIC: 2836 Biological Products, (No Diagnostic Substances)